Butterfly Network (BFLY) Scheduled to Post Quarterly Earnings on Thursday

Butterfly Network (NYSE:BFLY) will be announcing its earnings results after the market closes on Thursday, August 1st. Analysts expect the company to announce earnings of ($0.10) per share for the quarter. Butterfly Network has set its FY 2024 guidance at EPS.Investors interested in registering for the company’s conference call can do so using this link.

Butterfly Network (NYSE:BFLY) last announced its quarterly earnings data on Wednesday, May 1st. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.05. The company had revenue of $17.66 million for the quarter, compared to analysts’ expectations of $17.13 million. Butterfly Network had a negative net margin of 179.09% and a negative return on equity of 47.83%. During the same period in the previous year, the company posted ($0.17) EPS. On average, analysts expect Butterfly Network to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Butterfly Network Price Performance

Shares of BFLY opened at $1.06 on Tuesday. The company’s fifty day moving average is $1.01 and its two-hundred day moving average is $1.01. Butterfly Network has a 1 year low of $0.67 and a 1 year high of $2.59.

Insider Buying and Selling at Butterfly Network

In other Butterfly Network news, CFO Heather C. Getz sold 59,848 shares of the business’s stock in a transaction on Friday, May 3rd. The shares were sold at an average price of $0.95, for a total value of $56,855.60. Following the transaction, the chief financial officer now directly owns 2,699,469 shares of the company’s stock, valued at approximately $2,564,495.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In the last three months, insiders have sold 76,668 shares of company stock valued at $72,010. 27.28% of the stock is owned by company insiders.

Butterfly Network Company Profile

Butterfly Network, Inc develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians.